Literature DB >> 29038291

Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.

Takeo Goji1, Kazuhiko Takahara2, Manabu Negishi1,3, Hironori Katoh4,3.   

Abstract

Oncogenic signaling in cancer cells alters glucose uptake and utilization to supply sufficient energy and biosynthetic intermediates for survival and sustained proliferation. Oncogenic signaling also prevents oxidative stress and cell death caused by increased production of reactive oxygen species. However, elevated glucose metabolism in cancer cells, especially in glioblastoma, results in the cells becoming sensitive to glucose deprivation (i.e. in high glucose dependence), which rapidly induces cell death. However, the precise mechanism of this type of cell death remains unknown. Here, we report that glucose deprivation alone does not trigger glioblastoma cell death. We found that, for cell death to occur in glucose-deprived glioblastoma cells, cystine and glutamine also need to be present in culture media. We observed that cystine uptake through the cystine/glutamate antiporter xCT under glucose deprivation rapidly induces NADPH depletion, reactive oxygen species accumulation, and cell death. We conclude that although cystine uptake is crucial for production of antioxidant glutathione in cancer cells its transport through xCT also induces oxidative stress and cell death in glucose-deprived glioblastoma cells. Combining inhibitors targeting cancer-specific glucose metabolism with cystine and glutamine treatment may offer a therapeutic approach for glioblastoma tumors exhibiting high xCT expression.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  amino acid transport; cell death; cystine; glioblastoma; glucose; reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2017        PMID: 29038291      PMCID: PMC5712613          DOI: 10.1074/jbc.M117.814392

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

Review 2.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Authors:  Simran S Sabharwal; Paul T Schumacker
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

Review 3.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

4.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

5.  Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.

Authors:  L Sleire; B S Skeie; I A Netland; H E Førde; E Dodoo; F Selheim; L Leiss; J I Heggdal; P-H Pedersen; J Wang; P Ø Enger
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

6.  xCT deficiency accelerates chemically induced tumorigenesis.

Authors:  Ami Nabeyama; Ai Kurita; Kenichi Asano; Yasunobu Miyake; Takuwa Yasuda; Ikuo Miura; Gen Nishitai; Satoko Arakawa; Shigeomi Shimizu; Shigeharu Wakana; Hisahiro Yoshida; Masato Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

7.  Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.

Authors:  Monika D Polewski; Rosyli F Reveron-Thornton; Gregory A Cherryholmes; Georgi K Marinov; Kaniel Cassady; Karen S Aboody
Journal:  Mol Cancer Res       Date:  2016-09-22       Impact factor: 5.852

Review 8.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

9.  The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.

Authors:  Chun-Shik Shin; Prashant Mishra; Jeramie D Watrous; Valerio Carelli; Marilena D'Aurelio; Mohit Jain; David C Chan
Journal:  Nat Commun       Date:  2017-04-21       Impact factor: 14.919

10.  Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system.

Authors:  Yohei Katoh; Saki Michisaka; Shohei Nozaki; Teruki Funabashi; Tomoaki Hirano; Ryota Takei; Kazuhisa Nakayama
Journal:  Mol Biol Cell       Date:  2017-02-08       Impact factor: 4.138

View more
  20 in total

Review 1.  Role of the mitochondrial stress response in human cancer progression.

Authors:  Sheng-Fan Wang; Shiuan Chen; Ling-Ming Tseng; Hsin-Chen Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

2.  A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.

Authors:  James H Joly; Alireza Delfarah; Philip S Phung; Sydney Parrish; Nicholas A Graham
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

Review 3.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

4.  High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).

Authors:  Itsuki Yamaguchi; Shige H Yoshimura; Hironori Katoh
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

5.  Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.

Authors:  Nan Liu; Xiaoli Lin; Chengying Huang
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

6.  ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.

Authors:  Mei-Chun Chen; Li-Lin Hsu; Sheng-Fan Wang; Chih-Yi Hsu; Hsin-Chen Lee; Ling-Ming Tseng
Journal:  Cells       Date:  2020-07-01       Impact factor: 6.600

7.  KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.

Authors:  Pranavi Koppula; Kellen Olszewski; Yilei Zhang; Lavanya Kondiparthi; Xiaoguang Liu; Guang Lei; Molina Das; Bingliang Fang; Masha V Poyurovsky; Boyi Gan
Journal:  iScience       Date:  2021-05-25

Review 8.  Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.

Authors:  Pranavi Koppula; Yilei Zhang; Li Zhuang; Boyi Gan
Journal:  Cancer Commun (Lond)       Date:  2018-04-25

9.  Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.

Authors:  Xiaoguang Liu; Kellen Olszewski; Yilei Zhang; Esther W Lim; Jiejun Shi; Xiaoshan Zhang; Jie Zhang; Hyemin Lee; Pranavi Koppula; Guang Lei; Li Zhuang; M James You; Bingliang Fang; Wei Li; Christian M Metallo; Masha V Poyurovsky; Boyi Gan
Journal:  Nat Cell Biol       Date:  2020-03-30       Impact factor: 28.824

Review 10.  Targeting Glutamine Addiction in Gliomas.

Authors:  Marta Obara-Michlewska; Monika Szeliga
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.